BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7342108)

  • 1. Characteristics of the aggregation of platelets and the formation of prostaglandins (PGs) in rat.
    Hwang DH
    Prog Lipid Res; 1981; 20():543-7. PubMed ID: 7342108
    [No Abstract]   [Full Text] [Related]  

  • 2. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation by phospholipase A2 of prostaglandins and endoperoxides in platelets of normal and essential fatty acid-deficient rats.
    Vincent JE; Zijlstra FJ
    Adv Prostaglandin Thromboxane Res; 1978; 3():143-6. PubMed ID: 655005
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboxane synthase inhibition causes re-direction of prostaglandin endoperoxides to prostaglandin D2 during collagen stimulated aggregation of human platelet rich plasma.
    Orchard MA; Waddell KA; Lewis PJ; Blair IA
    Thromb Res; 1985 Sep; 39(6):701-10. PubMed ID: 3936223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.
    Lagarde M; Ghazi I; Dechavanne M
    Prostaglandins Med; 1979 Jun; 2(6):433-9. PubMed ID: 399526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet dysfunction and alteration of prostaglandin metabolism after chronic alcohol consumption.
    Arai M; Okuno F; Nagata S; Shigeta Y; Takagi S; Ebihara Y; Kobayashi T; Ishii H; Tsuchiya M
    Scand J Gastroenterol; 1986 Nov; 21(9):1091-7. PubMed ID: 3810010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformations of exogenous arachidonic acid in human platelets in the presence of oleic- and eicosapentaenoic acids.
    Srivastava KC
    Prostaglandins Leukot Med; 1985 Apr; 18(1):31-7. PubMed ID: 2987977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous antiaggregatory prostaglandins can contribute to inhibition of hemostasis: a pharmacological study in vivo in humans.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():248-53. PubMed ID: 2821758
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats.
    Mallarkey G; Smith GM
    Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differences in 12-hydroxyeicosatetraenoic acid and thromboxane B2 release from guinea pig platelets.
    Mike I; Ichikawa Y; Shimizu T; Honda ZI; Seyama Y; Ishii A
    Prostaglandins; 1991 Nov; 42(5):431-40. PubMed ID: 1763200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase.
    Raz A; Aharony D
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):507-15. PubMed ID: 705027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins and platelet aggregation.
    Smith JB
    Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
    Sokolov EI; Lavrenova NIu; Goloborodova IV
    Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium stimulates thromboxane B2 formation in human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C; van den Berg R; Thomas C
    Prostaglandins Med; 1981 Nov; 7(5):421-9. PubMed ID: 6798588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
    Nishizawa EE; Williams DJ; Connell CL
    Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of methyl mercury on platelets: induction of aggregation and release via activation of the prostaglandin synthesis pathway.
    Macfarlane DE
    Mol Pharmacol; 1981 May; 19(3):470-6. PubMed ID: 7266471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.